Why it fits
Sedation, weight gain, EPSE, prolactin elevation, constipation, QT prolongation, sexual dysfunction, emotional blunting
Loading…
Sedation, weight gain, EPSE, prolactin elevation, constipation, QT prolongation, sexual dysfunction, emotional blunting
NMS, severe akathisia, bowel obstruction with clozapine, torsades risk, aspiration.
Temporal association with antipsychotic initiation, dose change, or depot timing.
Separates the Medication Side Effects / Iatrogenic Toxicity / QT Risk group. It is not specific to Antipsychotic adverse effects.
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group — not specific to Antipsychotic adverse effects
Rows marked “Whole group”: Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group — not specific to Antipsychotic adverse effects
Sedation, weight gain, EPSE, prolactin elevation, constipation, QT prolongation, sexual dysfunction, emotional blunting
NMS, severe akathisia, bowel obstruction with clozapine, torsades risk, aspiration.
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group.
Temporal association with antipsychotic initiation, dose change, or depot timing.
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group.
Constipation with clozapine is a red flag, not a nuisance side effect Clozapine constipation and myocarditis are high-risk problems Escalate early, review bowels deliberately, maintain active surveillance during early titration Early activation is a common misread Clinical toxicity can occur even when history suggests a "usual dose" Check ammonia if unexplained confusion develops on valproate
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group.
ECG / QT assessment, Urea, electrolytes, creatinine, Inflammatory markers (CRP/ESR), Creatine kinase
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group.
None listed
Clinical reference — not validated decision support. Review before use.